Story perspectives

EU Aims for 11.1% Boost in Clinical Trials, Creating 35,000 Jobs

4/16/2026

Summary

Story summary

The European Medicines Agency and the European Commission aim to raise EU clinical trials by 11.1 percent, potentially adding 500 multinational trials over five years.
The initiative could create 35,000 new trial places and generate about €4 billion in economic impact.
Regulatory fragmentation and operational complexity hinder the EU's competitiveness in clinical research.
Industry representatives urge policymakers to adopt a unified regulatory system to streamline processes and reclaim Europe’s position.

1 of 1

Story summary

The European Medicines Agency and the European Commission aim to raise EU clinical trials by 11.1 percent, potentially adding 500 multinational trials over five years.
The initiative could create 35,000 new trial places and generate about €4 billion in economic impact.
Regulatory fragmentation and operational complexity hinder the EU's competitiveness in clinical research.
Industry representatives urge policymakers to adopt a unified regulatory system to streamline processes and reclaim Europe’s position.